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Abstract
OBJECTIVES: The resection of thymic tumours requires completeness and may be technically challenging due to the anatomical
proximity of the delicate mediastinal structures. An open approach by sternotomy is still recommended in all cases with locally
extended disease. Video-assisted thoracoscopic surgery is feasible, but limited by the two-dimensional vision and the impaired mobility
of the instruments. We evaluated the da Vinci® Surgical System for the resection of various mediastinal pathologies, particularly
thymomas.
METHODS: Among 105 patients operated on by robotic assisted thoracoscopic surgery (RATS) for mediastinal tumours between 27
August 2004 and 12 July 2011, 20 patients with thymomas were studied prospectively. Of these, 10 males with a median age of 53
years, with a well-circumscribed thymic lesion on computed tomography (CT) and a diameter of <6 cm were resected by RATS alone,
and selected ones (n = 3), with a diameter of >6 cm, underwent a hybrid procedure with a contralateral thoracotomy on the side of the
main tumour extension. A regular follow-up with chest CT scans was performed every 6 months.
RESULTS: Thymoma resection was complete in all patients. Partial pericardial resection was needed in ﬁve and pulmonary resection in
two patients. Eighty-ﬁve percent of patients had an R0 resection. Histological classiﬁcations included thymoma WHO type A (n = 3), AB
(n = 8), B1–2 (n = 5) and B3 (n = 4). All B3 thymomas received adjuvant radiotherapy. No intraoperative complications occurred. The
median hospitalization time was 5 days (range 2–14 days). There were no local, but two pleural, recurrences. After a median observa-
tion time of 26 months, 19 patients (95%) are alive.
CONCLUSIONS: Well-circumscribed thymomas can be safely and completely resected with the da Vinci® Surgical System with excellent
short- and mid-term outcomes. Selected tumours with large diameters may be resectable using a hybrid procedure combining RATS
with a thoracotomy.
Keywords: Thymoma • da Vinci® Surgical System • Robotic-assisted thymectomy • Hybrid procedure
INTRODUCTION
Mediastinal pathologies are classiﬁed according to their anatomical
localization. In the anterior mediastinum, they typically originate
from the thymus, while in the middle compartment, lymphatic
disorders and in the posterior compartment, neurogenic tumours
are located. The surgical approach and the type of resection are
often technically challenging due to the pathological variety, the
degree of tumour spread as well as the anatomical proximity of
large vessels or nerves. Therefore, open surgical techniques such
as sternotomy or thoracotomy are recommended. This is consid-
ered particularly important for thymomas since complete surgical
resection is the key for successful treatment [1, 2]. However, due
to the technical improvements in video-assisted thoracoscopic
surgery (VATS), endoscopic access in the treatment of thymomas
has become more and more popular in the last decade [3]. In the
hands of skilled surgeons, the implementation of thoracoscopic
procedures has shifted from diagnostic procedures to complex
radical resections.
With the introduction of the da Vinci® Surgical System, a tool
with unexpected prospects has become an additional option for
endoscopic resections in thoracic surgery [4–6]. The outstanding
visibility using a robotic-assisted system is due to its three-
dimensional vision combined with the magniﬁcation of the op-
erating ﬁeld and the dexterity of the instruments which facilitates
surgery with spectacular precision and security in contrast to
VATS. Although the access through trocar ports is identical to the
VATS procedure, the modality of surgical resection is different
and comparable to what the surgeon is familiar with from the
open surgical approach except for the lack of tactility. Hence the
endoscopic surgeon is not limited by a two-dimensional view
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and dissatisfying dissection of the anatomical structures due to
limited manoeuvrability of the surgical instruments in a single di-
mension. RATS has become an established approach in many
centres for thymectomy in patients with myasthenia gravis
(MG) [7]. However, only a few reports exist on its application in
thymomas [4–8].
Here, we report our experience of a single academic institu-
tion with minimally invasive resections of thymomas with the da
Vinci® Surgical System.
MATERIALS AND METHODS
Out of a cohort of the ﬁrst 105 consecutive patients (47 men)
who underwent the surgical resection of thoracic tumours with
the da Vinci® Surgical System at the University Hospital Zurich
between 27 August 2004 and 12 July 2011, 68 patients had a
neoplasm in the anterior mediastinum (65%). In 58 of those, a
thymic pathology was found (85.3%). For this study, we per-
formed a sub-analysis of the 20 patients who underwent a
robotic-assisted thymectomy for an underlying thymoma.
Resection with the da Vinci® Surgical System (three arms) was
evaluated for all patients with a mediastinal pathology. Exclusion
criteria were a lesion size of >6 cm, obvious signs of the invasion
of vital organs, and expected unfeasibility of a single lung venti-
lation. Later on, the approach was extended to a hybrid proced-
ure combining RATS for the mediastinal dissection from one
side and a thoracotomy for the main tumour resection from the
opposite side in the selected patients with large (up to 8 cm),
mainly paramediastinal tumours.
The preoperative workup of the patients included CT scan,
lung function testing, ECG and basic blood tests in all patients.
In addition, the speciﬁc parameters such as ACh-receptor,
anti-MuSK and anti-Titin antibodies were measured in patients
with MG before the operation. Clinical staging included medical
history and physical examination, CT or optional positron emis-
sion tomography scan, and a neurological workup in patients
with MG. The intervention was performed preferentially from
the left side except for tumours extending predominantly to the
right side.
All resections were performed by three thoracic surgeons at
our institution who were experienced in extended open as well as
minimally invasive surgery including RATS. Individual patient
consent was waived. The patient characteristics and perioperative
outcome data were collected in a prospective database and a de-
scriptive statistical analysis was performed retrospectively.
Medical charts were reviewed for demographic data, clinical
presentation, diagnostic investigations, side of the approach,
tumour invasion, histological diagnosis and staging, post-
operative morbidity and mortality, follow-up and additional
therapy. The follow-up data were collected through regular
outpatient visits and individual phone calls if the follow-up was
conducted in another centre.
Operative technique
All interventions were performed under general anaesthesia with
single lung ventilation. The procedure was conducted with add-
itional CO2 insufﬂation (maximum pressure 6–8 mmHg) as it was
found to facilitate the dissection along the anatomical layers,
enlarge the operative ﬁeld and clear the fume in front of the
camera. We use three of the four robotic arms of the new da
Vinci® SiHD Surgical System and a 30° camera for thymectomies.
The positioning of the patients depended on the localization
of the tumour and was carried out according to an earlier report
[9, 10]. In brief, all patients were positioned supine with the inci-
sion side elevated by 30°. The arm of the patient was positioned
parallel to the trunk allowing for free access to the mid-axillary
line.
With increasing experience, we approached the surgical access
from the right side (ﬁrst 15 patients) to the left side for two
main reasons: first, coming through the left thoracic cavity, the
right phrenic nerve is protected by the superior vena cava in the
delicate region of the right upper thymic horn (venous conﬂu-
ence with the left brachiocephalic vein). Due to a more ventral
localization, the left phrenic nerve is easier to identify and pre-
serve. Secondly, accessory thymic tissue in the aortic-pulmonary
window is accessible only from the left side.
The incision for the camera port is performed in the 5th inter-
costal space in the anterior axillary line. The port for the left
robotic arm is subsequently introduced under the direct vision
in the 6th intercostal space in the mid-clavicular line and the
right arm in the 3rd intercostal space in the anterior axillary line.
In order to create more space in the thoracic cavity, we lift
the thoracic cage up by 2–3 cm with the camera arm of the da
Vinci® Surgical System once the camera arm is positioned.
For larger lesions (>6 cm) without invasiveness of vital struc-
tures on CT scan, we developed the technique of a Hybrid pro-
cedure in order to avoid a sternotomy or clamshell incision. This
technique is typically applied in tumours arising from the
midline of the mediastinum but with the main tumour mass
being located paramediastinally. The mediastinal dissection of
the tumour from the anonymous vein, the pericardium and the
retrosternal region is done with the da Vinci® Surgical System on
the side where the lesion is located centrally ﬁrst. Subsequently,
a standard anterolateral thoracotomy is conducted from the
contralateral and the tumour is freed by an open technique
(with rib spreading). The advantage of this technique is that crit-
ical structures in the upper mediastinum not controllable by an
access like a thoracotomy, have already been dissected minimal-
ly invasively and hence the resection of the tumour can be com-
pleted and the specimen removed through the thoracotomy.
RESULTS
Overall, 68 patients with lesions in the anterior mediastinum
were resected by RATS; 58 of those were of thymic origin
(85.3%) (Table 1). The current study population of thymomas
(n = 20) included 10 females and 10 males with a median age of
53 years (range 21–77 years) and a median body mass index of
26.5 kg/m2 (range 19.0–37.0 kg/m2). MG was prevalent in 12
(60%) patients. The preoperative lung function test with forced
expiratory volume in one second (FEV1), forced expiratory vital
capacity (FVC) and diffusing capacity of the lung for carbon
monoxide (TLCO) were available in 17 patients and are summar-
ized in Table 2. All 20 procedures were performed as planned
by RATS, three with a Hybrid approach.
There were six patients who needed an extended resection in-
cluding the pericardium (n = 5) or a lung wedge resection (n = 1).
Half of these were done entirely endoscopically and half with a
Hybrid approach.
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No emergency conversion to an open thoracotomy was ne-
cessary. There were 15 patients who underwent a total thymec-
tomy (80.0%). In ﬁve patients with small, well-circumscribed
thymomas in the main body of the thymus in the absence of
MG, a thymectomy without the complete resection of the upper
horns was performed. A R0 resection was achieved in 85.0% of
the patients and a R1 resection in three (15.0%) patients (two
total RATS and one Hybrid approach). R1 resections were found
in tumours either adjacent to the retrosternal pleura, pericar-
dium, vena cava superior or phrenic nerves without macroscopic
inﬁltration. Histology and staging data are summarized in
Table 3.
The median hospital length of stay of all 20 patients was 5
days (range 2–14 days), in the subgroup of RATS, 4 days (range
2–14 days), and in the hybrid group, 8 days (range 8–13 days).
Only two patients suffered from postoperative complications
(10.0%); one developed a sero-pneumothorax and one supra-
ventricular arrhythmias. None of the patients needed
re-intervention or had to be readmitted to the hospital within
the ﬁrst 90 days of dismissal. Adjuvant radiotherapy was con-
ducted in all four patients with a B3 thymoma and in one
patient with a B2 thymoma due to the R1 resection. The median
follow-up time was 26 months (range 0.1–6.6 years), with one
patient lost to the follow-up. Two patients (11.1%) had a recur-
rence in the pleura after 1.3 and 4.9 years. One of those patients
(5.0%) died because of the recurrence at 5.2 years after surgery.
DISCUSSION
Mediastinal pathologies are frequently asymptomatic and ﬁrst
noted on a routine chest radiograph or increasingly by CT. In
any case, a chest CT scan with contrast medium should be con-
ducted for further evaluation of the lesion as its speciﬁc
localization and appearance are highly suggestive of the various
differential diagnoses. It is therefore essential for the planning of
further diagnostic and therapeutic strategies. Primary tumours in
the anterior mediastinum account for half of all mediastinal
masses. The most common primary anterior mediastinal
tumours are thymomas. Non-malignant lesions include thymic
cysts, lymphangioma, intrathoracic goitre and ectopic parathy-
roid adenoma [11]. Understanding of the pathology, clinical pres-
entation and radiological presentation of the main tumour types
is mandatory in the safe and efﬁcient work-up of a mediastinal
mass. In spite of the improvement of imaging techniques, tissue
is often needed for histological diagnosis and remains crucial for
deﬁnitive treatment [12–14].
Nowadays in experienced centres, the majority of diagnostic
but also many therapeutic procedures for thoracic malignancies
are approached through a minimally invasive access. Shorter
hospital stay, less pain, smaller and hence less noticeable scars as
well as faster postoperative rehabilitation are sufﬁciently good
reasons to promote endoscopic procedures. Furthermore, adju-
vant treatment, if necessary, is better tolerated.
Irrespective of the approach, the complete surgical resection is
of paramount importance in the treatment of thymomas and is
considered as the most important prognostic factor. Any com-
promise in achieving a radical resection due to an inadequate
approach is undesirable. In more advanced tumour stages, par-
ticularly after an R1 resection, adjuvant radiotherapy is commonly
considered [15]. Due to the localization of thymic tumours in a
narrow compartment with proximity to vital and vulnerable ana-
tomical structures, traditionally an open approach is performed,
via sternotomy or, in lesions located predominantly on one side,
by thoracotomy or a hemi-clamshell incision. Thymic tumours
have to be resected with the surrounding tissue in order to
achieve the microscopic clear margins. Applying the da Vinci®
Surgical System offers a clear beneﬁt compared with VATS and in
small well-circumscribed tumours, even with an open approach.
This statement is scientiﬁcally difﬁcult to prove, but reﬂects our
own clinical experience shared by those who are skilled in the use
of RATS. Due to the three-dimensional magniﬁed view and the
dexterity of the instruments, the surgeon is capable of performing
Table 3: Histology and staging data
N Percentage
Masaoka stage [6]
I 8 40
II 11 55
III 1 5
IV 0 0
WHO classification [7, 8]
A 3 15
AB 8 40
B1 2 10
B2 3 15
B3 4 20
Tumour diameter (mm) Median Range (min–max)
40 25–80
Extent of resection
R0 17 85
R1 3 15
Total RATS 2/3 67
Hybrid 1/3 33
Table 1: Thymic pathologies resected with the da Vinci®
Surgical System
N Percentage
Anterior mediastinal lesions 68
Thymic disease 58/68 85.3
MG only 25
Thymoma without MG 8
Thymoma with MG 12
Thymic cyst 4
Thymic hyperplasia 9
Table 2: Preoperative pulmonary function testing
Median Range (min–max)
FEV1 (l) 2.66 1.49–5.24
FEV1 (% predicted) 94 61–126
FVC (l) 3.2 1.78–6.23
FVC (% predicted) 96 55–123
TLCO (% predicted) 99 67–114
D. Schneiter et al. / European Journal of Cardio-Thoracic Surgery290
surgery with high precision and even extending the resection to
the pericardium and the lung without any difﬁculties. In the
majority of smaller thymomas, the complete resection can be
achieved by robotic-assisted thymectomy in a safe and effective
method. However, if the tumour exceeds a certain size or inﬁl-
trates vital organs, conversion to sternotomy or thoracotomy is
still the appropriate approach.
In recent years, thymectomy performed via robotic-assisted
thoracoscopy (RATS) has gained importance and has been
proven to achieve equivalent results to the VATS approach
or open surgery in MG [7, 16]. However, little information
about robotic resection for thymomas is found in the literature
and no randomized study of any surgical approach is available
[4–7, 17–19].
Since the complete resection of thymomas is crucial, the
surgeon must achieve R0 resection whenever technically
feasible, and we followed this paradigm in all cases. The intrao-
perative evaluation by the surgeon as to complete resection is
essential because the ﬁnal assessment by the pathologist is difﬁ-
cult as he is not able to appreciate the intraoperative situation.
This is commonly the case in tumours invading the pericardium.
The thymoma is adherent to the pericardium, therefore, the
pericardium is resected together with the thymoma. The micro-
scopic ﬁndings will still show tumour inﬁltration at the resection
margin, yet there is absolutely no contact of the tumour with
the underlying structure. Therefore, careful examination of the
resected specimen by the pathologist in close collaboration with
the surgeon is decisive, particularly when adjuvant radiotherapy
is considered.
After more than 10 years of experience with thymectomy for
MG without thymomas by VATS, we switched to the RATS
approach in April 2004. Having experienced the technical advan-
tages, we subsequently included smaller lesions up to 3 cm and
over time also larger thymomas up to 6 cm in diameter.
In our series, 85% of patients underwent complete resection.
Of the three patients with R1 resection, it was performed entirely
endoscopically on two, and on one by the Hybrid procedure
developed in our centre. The latter was performed in a woman
suffering from severe, therapy-resistant MG with a large
thymoma (WHO-Typ B3, Masaoka II) located paramediastinally
to the left side who refused having a sternotomy. The mediastin-
al part of the thymectomy including the dissection of the an-
onymous vein was done from the right side and the main
dissection and exstirpation of the large tumour of 8 cm, through
an anterolateral thoracotomy from the left side. Eighteen
months after extended surgical resection (pericardium with re-
construction and paramediastinal wedge-resection of the left
upper lobe of the lung), the MG has improved and the CT scan
shows no signs of local or distant recurrence. In conclusion,
radical resection of well-circumscribed thymomas with the da
Vinci® Surgical System is effective and safe and provides a short
hospital stay and rapid recovery. Local control seems to be com-
parable to an open approach based on this limited experience.
Larger thymomas or lesions with invasion of the surrounding
vessels are still preferentially resected by an open approach. In
carefully selected patients, a hybrid may achieve equal radicality
with the avoidance of a sternotomy, which is an advantage with
respect to potentially associated morbidity and for cosmetic
reasons, especially in female patients. Short- to mid-term out-
comes are comparable with the data reported in the literature.
Further and larger clinical studies with the longer follow-up data
are required to substantiate our conclusion.
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APPENDIX. CONFERENCE DISCUSSION
Dr A. Duranceau (Montreal, QC, Canada): Can you tell us if you had any
technical problem with access to the apices of the gland in the neck?
Dr Schneiter: We haven’t had problems with this access. We always come
from the left side when we do thymectomies, and we have never had
problems to go up to the neck. If we had not been sure that we had done
the right operation, we would convert or we would do an additional incision
in the jugulum.
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Dr S. Bolukbas (Wiesbaden, Germany): My questions would be, is R1 resec-
tion really a complete resection? And second, we are all surgeons and inter-
ested in demanding operations, and you perform a minimally invasive
intrathoracic surgery but afterwards it ends up with a thoracotomy. What is
the advantage for the patient?
Dr Schneiter: As to your ﬁrst question, I didn’t say that it was a com-
plete resection. I said it is a complete thymectomy. But in two patients it
was not a complete resection because it was an R1 resection, you are
right. And concerning the second question, there is a possibility to do
either a hemiclamshell or a clamshell incision, or a sternotomy, and those
patients were women, all of them, and they decided it might look better
if they only had three small incisions that you don’t see very well on one
side and a submammary incision on the other side. But you are right, it
is always possible to do it in a more open method. But in this case we
tried to combine this and it worked out ﬁne. We could do it completely
in all these cases.
Dr F. Detterbeck (New Haven, CT, USA): Two quick comments. I commend
you for pushing the envelope in trying to deﬁne what we can do. I would
exercise a word of caution, though. I think we have to be careful. We have
good results with surgery with complete resection, and we should not be
compromising that by trying to do a minimally invasive approach.
The other comment is within the ITMIG group we have spent a fair
amount of time trying to deﬁne some principles about doing minimally inva-
sive resection. Those are going to be published in the Journal of Thoracic
Oncology within the next month, and I would urge people that are doing this
to try to adhere to some of those principles, because I think it will help us
sort out a little bit better where this ﬁts and how it should be done.
Dr Schneiter: I completely agree. I think you should never do a minimally
invasive resection if you are not doing it in the same way as you do it open. If
this would be the case, you should convert, and this is what we did when we
had problems.
Dr T. Lerut (Leuven, Belgium): Just in follow-up to what Dr Detterbeck said,
I would caution to call 39-month follow-up long-term follow-up. That is
medium follow-up in thymoma surgery.
Dr Schneiter: This is true. This is what we quoted.
Dr J. Kuzdzal (Krakow, Poland): I know that it is not the main topic of your
presentation, but I would like to ask you to say a little bit more about
the non-thymoma thymectomies for myasthenia. How could you deﬁne the
extent of the thymectomy in these cases? Was it a simple thymectomy or an
extended or maximal one and how far were you able to dissect the thymus
and the fatty tissue in the upward direction, I mean towards the neck,
towards the thyroid gland?
Dr Schneiter: We feel that we have a very good vision of the upper part of
the thymus, and as I said before, we always come from the left side, so we
have the possibility to go in the aortopulmonary window and go beneath the
phrenic nerve, and we go to the base of the heart as well. So it was quite
extended but not maximally extended as described by Jarezki. But we took
out all the tissue we had from the left side, and we opened even the pleura
on the other side and looked on the right side, and if there was more tissue
we took it out as well.
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